Compare · NSYS vs TMO
NSYS vs TMO
Side-by-side comparison of Nortech Systems Incorporated (NSYS) and Thermo Fisher Scientific Inc (TMO): market cap, price performance, sector, and recent activity on the wire.
Summary
- NSYS operates in Technology, while TMO operates in Industrials - the two are in different parts of the market.
- TMO is the larger of the two at $257.53B, about 8744.2x NSYS ($29.5M).
- Over the past year, NSYS is up 2.0% and TMO is up 26.8% - TMO leads by 24.8 points.
- TMO has hit the wire 6 times in the past 4 weeks while NSYS has been quiet.
- TMO has more recent analyst coverage (25 ratings vs 0 for NSYS).
- Company
- Nortech Systems Incorporated
- Thermo Fisher Scientific Inc
- Price
- $10.08-10.08%
- $690.13-0.92%
- Market cap
- $29.5M
- $257.53B
- 1M return
- -12.77%
- +4.77%
- 1Y return
- +2.02%
- +26.83%
- Industry
- Industrial Machinery/Components
- Industrial Machinery/Components
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 6
- Recent ratings
- 0
- 25
Nortech Systems Incorporated
Nortech Systems Incorporated operates as an electronic manufacturing services company in the United States, Mexico, and China. It offers a range of value added engineering, technical and manufacturing, and support services, including project management, designing, testing, prototyping, supply chain management, and post-market services. The company also provides manufacturing and engineering services for medical devices, printed circuit board assemblies, wire and cable assemblies, and higher level electromechanical assemblies. In addition, it offers repair services. The company serves original equipment manufacturers in the aerospace and defense, medical, and industrial markets through business development teams and independent manufacturers' representatives. Nortech Systems Incorporated was founded in 1990 and is headquartered in Maple Grove, Minnesota.
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for use in laboratory, on production line, and in field for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, and calibration verification fluids; ImmunoCAP for allergy and asthma tests, and EliA for autoimmunity tests; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Services segment provides laboratory refrigerators and freezers, ultralow-temperature freezers, and cryopreservation storage tanks; temperature control, sample preparation and preservation, centrifugation, and biological safety cabinet products; water analysis instruments; laboratory plastics products; laboratory chemicals; and pharma services. The company offers products and services through a direct sales force, customer-service professionals, electronic commerce, third-party distributors, and catalogs. It has a strategic alliance with the University of California, San Francisco. The company was incorporated in 1956 and is based in Waltham, Massachusetts.
Latest NSYS
- SEC Form 4 filed by Director Peris Jose Antonio
- SEC Form 4 filed by Director Mcmanus Ryan
- SEC Form 4 filed by Director Kunin David B
- SEC Form 4 filed by Director Fredregill Amy S.
- SEC Form 4 filed by Director Kruse Stacy A
- SEC Form 10-Q filed by Nortech Systems Incorporated
- Nortech Systems Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Nortech Systems Reports Second Quarter Results
- Nortech Systems Incorporated to Report Second Quarter 2026 Financial Results and Hold a Conference Call on August 12, 2026
- SEC Form S-8 filed by Nortech Systems Incorporated
Latest TMO
- SEC Form 4 filed by Director Weisler Dion J
- SEC Form 4 filed by Director Sperling Scott M
- SEC Form 4 filed by Director Lynch Karen S
- SEC Form 4 filed by Director Johnson Jennifer M
- SEC Form 4 filed by Director Keith R. Alexandra
- Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 21, 2026
- Thermo Fisher Scientific Launches Gibco™ CHO-K1 Catalog Panel Media and Feed to Accelerate Biologics Development
- Thermo Fisher upgraded by UBS with a new price target
- CLSA initiated coverage on Thermo Fisher with a new price target
- Executive Vice President Shafer Michael D covered exercise/tax liability with 790 shares, decreasing direct ownership by 4% to 20,204 units (SEC Form 4)